LATEST TRIALS

  • Head And Neck Cancer
    REPORT; REirradiation and PD-1 blockade On Recurrent squamous cell head and neck Tumors
  • Lymphoma
    Biomarker driven and dose intensified chemoimmunotherapy with early CNS prophylaxis in patients less than 65 years with high risk diffuse large B-cell lymphpoma
  • Lymphoma
    Biomarker driven and dose intensified chemoimmunotherapy with early CNS prophylaxis in patients less than 65 years with high risk diffuse large B-cell lymphpoma

NORDIC COOPERATION

Norway Norway Sweden Finland Aarhus Herlev Copenhagen